MicroRNAs in the regulation of autophagy and their possible use in age-related macular degeneration therapy

Ageing Res Rev. 2021 May:67:101260. doi: 10.1016/j.arr.2021.101260. Epub 2021 Jan 28.

Abstract

Age-related macular degeneration (AMD) is a progressive sight-impairing disease of the elderly. The pathogenic mechanisms of AMD are not well understood although both genetic and many environmental factors have been associated with the development of AMD. One clinical hallmark of AMD is the detrimental aggregation of damaged proteins. Recently, it has been suggested that the weakening of autophagy clearance is an important mechanism in the pathogenesis of AMD. Autophagy is important in the removal of damaged or no longer needed cellular material and its recycling. A considerable number of autophagy-targeting microRNAs (miRNAs), small RNA molecules and epigenetic regulators have been found to be either up- or down-regulated in AMD patients and experimental models. The important role of autophagy-targeting miRNAs is supported by several studies and can open the prospect of the use of these miRNAs in the therapy for AMD.

Keywords: Age-Related macular degeneration; Autophagy; Exosome; Extracellular vesicle; MicroRNA; Retinal pigment epithelium.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Aged
  • Autophagy
  • Humans
  • Macular Degeneration* / genetics
  • Macular Degeneration* / therapy
  • MicroRNAs* / genetics
  • Retinal Pigment Epithelium

Substances

  • MicroRNAs